戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 .e., anxiety, tachycardia, hypertension, and tachypnea).
2 onspecific symptoms of cough, coryza, and/or tachypnea.
3 ted to an outside institution with fever and tachypnea.
4 8) were associated with faster resolution of tachypnea.
5 ed the firing of pre-I neurons, resulting in tachypnea.
6 g for ruling out pneumonia is the absence of tachypnea.
7 /= 1.1 joule/L, extubation proceeded despite tachypnea.
8 d in a 3-month-old infant who presented with tachypnea.
9                    At the time of admission, tachypnea (27% vs 60%; OR, 0.24; P = .031) and respirato
10 poxemia (45% vs 26%), crackles (69% vs 62%), tachypnea (85% vs 80%), or fever (20% vs 16%) and less l
11     Patients with more severe HF had greater tachypnea and a smaller tidal volume (VT) at a given exe
12 ed work of breathing are more important than tachypnea and auscultatory findings.
13 on were concerns over patient discomfort and tachypnea and concerns over hypercapnia, acidosis, and h
14                                              Tachypnea and hypoxemia resolved faster in older childre
15       We report an infant who presented with tachypnea and interstitial infiltrates on chest radiogra
16 a SUNDS victim who suffered sudden nocturnal tachypnea and lacked pathogenic variants in known arrhyt
17 ne and combined deficits had higher rates of tachypnea and pneumonia during treatment.
18 ansgenic recipients of CD8(+) CTLs exhibited tachypnea and progressive weight loss, becoming moribund
19 r, increased locomotion, grooming, diarrhea, tachypnea and ptosis.
20 CRP >=80 mg/L plus age/temperature-corrected tachypnea and/or chest indrawing) or current World Healt
21 o had sepsis, defined as fever, tachycardia, tachypnea, and acute failure of at least one organ syste
22 STV-infected pigs developed severe cyanosis, tachypnea, and acute interstitial pneumonia, with RESTV
23 is, respiratory distress syndrome, transient tachypnea, and apnea.
24 rogression, particularly the onset of fever, tachypnea, and bacteremia, should be useful for evaluati
25 omboembolism, newborn Apgar score, transient tachypnea, and birth weight.
26 ereafter, the infected rats exhibited fever, tachypnea, and hypertension that persisted for 24 to 36
27 zed by increased frequency due to periods of tachypnea, and increased apneas, as in RTT patients.
28 iary atresia developed fevers, hematochezia, tachypnea, and laboratory evidence of hepatitis and panc
29       Signs of illness included tachycardia, tachypnea, and leukopenia.
30 ed seconds, and were accompanied by moaning, tachypnea, and oxygen desaturation.
31                 Oxygen saturation of </=90%, tachypnea, and tachycardia were each associated with an
32                                              Tachypnea as a marker of respiratory distress is sensiti
33                                  Reliance on tachypnea as a preextubation trial failure criterion is
34           This study evaluates the impact of tachypnea as an indicator of ventilatory failure during
35 suggesting respiratory distress or transient tachypnea at lower catecholamine levels.
36 ection (pneumonia and cellulitis), response (tachypnea, bandemia, and tachycardia), and organ dysfunc
37  the ventral part of the lateral PAG induced tachypnea but inhibited pre-I cell firing, whereas stimu
38                                       Fever, tachypnea, cough, rhinorrhea, retractions of the chest w
39 G was normal and identical on each side, but tachypnea could not be elicited in the pre-BotC of SSP-S
40 developed an identical illness consisting of tachypnea, decreased activity, and hunched posture.
41 eexposure baseline (SAW(grp)) or exaggerated tachypnea during exercise.
42 onger duration of fever, higher morbidity of tachypnea/dyspnea, pleural effusion, diarrhea, hepatospl
43                           Cough, rhinorrhea, tachypnea, fever, abnormal breath sounds, and hypoxia we
44 The parents reported a history of persistent tachypnea, grunting, and episodic nonproductive cough wi
45                                  Very severe tachypnea (&gt;=26 breaths/minute) was common (56%); 21% re
46 ach for systolic hypotension [</=100 mm Hg], tachypnea [&gt;/=22/min], or altered mentation).
47 anic-like responses, defined as tachycardia, tachypnea, hypertension, and increased anxiety as measur
48  dose-dependent blockade of the tachycardia, tachypnea, hypertension, and SI responses after lactate
49 ed acute lung injury had fever, tachycardia, tachypnea, hypotension, and prolonged hypoxemia compared
50 ners were more likely to present with fever, tachypnea, hypoxemia, and markedly elevated inflammatory
51  the restrictive changes leading to exercise tachypnea in HF patients.
52 tibiotics may be unnecessary for physiologic tachypnea in otherwise well newborns.
53 ory response syndrome criteria (tachycardia, tachypnea, leukocytosis, and fever) in surgical ICU pati
54 ne pulmonary MRI measures of metronome-paced tachypnea (MPT)-induced dynamic hyperinflation and its r
55 nvasive ventilation compared with high-flow, tachypnea, neck muscle use, abdominal paradox, drowsines
56                                   Persistent tachypnea of infancy (PTI) is a specific clinical entity
57 me (OR = 1.09; 95% CI, 1.01-1.19), transient tachypnea of the newborn (OR = 1.10; 95% CI, 1.02-1.19),
58 s syndrome, apnea, sepsis, anemia, transient tachypnea of the newborn, infective pneumonia, asphyxia,
59  Severe respiratory complications, transient tachypnea of the newborn, surfactant use, and bronchopul
60                 In intact rats, DLH produced tachypnea only when injected into the pre-Botzinger comp
61  recording the presence of terminal illness, tachypnea or hypoxemia, septic shock, platelet count <15
62 io, 6.1; 95% confidence interval, 3.6-10.2), tachypnea or hypoxia (2.7, 1.6-4.3), septic shock (2.7,
63 , absence of a febrile response (P = 0.003), tachypnea (OR 1.9, P = 0.001), leukopenia or leukocytosi
64  hypotension (OR = 4.8; 95% CI, 2.8 to 8.3), tachypnea (OR = 2.9; 95% CI, 1.7 to 4.9), diabetes melli
65 ein was associated with a longer duration of tachypnea (P = 0.044).
66 rvable differences in the physical response (tachypnea, piloerection, lethargy, etc), or intra-abdomi
67 entilator inflation time (TI,vent) can cause tachypnea, probably as a response to lung inflation.
68 hypothesis that a decrease in TI,vent causes tachypnea, prolongation of exhalation, and a decrease in
69 hese, 97 were successfully extubated despite tachypnea ranging from 32 to 56 breaths/min, when combin
70 sitivity, 80%-92%; specificity, 47%-54%) and tachypnea (respiratory rate >40 breaths/min; LR, 1.5 [95
71                                              Tachypnea, respiratory distress, deep breathing, shock,
72 sification 2, the patient developed afebrile tachypnea, tachycardia, and an increasing oxygen require
73 e blood culture or the combination of fever, tachypnea, tachycardia, clinically suspected infection,
74 ed States were included if they had hypoxia, tachypnea, tachycardia, or fever, and SARS-CoV-2 variant
75                    Common physical signs are tachypnea, tachycardia, rales, and cyanosis.
76  flow) of venous return, and metronome-paced tachypnea to induce dynamic hyperinflation.
77         The dolphin showed clinical signs of tachypnea, transient dyspnea, and mild tachycardia and d
78                 Some of the stimulus for the tachypnea was possibly due to increased imposed work of
79                                           If tachypnea was the reason for failure, work of breathing
80 et WHO criteria for nonsevere pneumonia with tachypnea were randomly assigned to a 3-day course of a
81 randomization (defined as COPD exacerbation, tachypnea, wheezing, worsening bronchitis, worsening dys
82  reduce TI,vent in patients with COPD caused tachypnea, yet prolonged the time for exhalation with co
83 icillin for patients who have pneumonia with tachypnea, yet trial data indicate that not using amoxic